Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-02-08
2011-02-08
Vivlemore, Tracy (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A
Reexamination Certificate
active
07884196
ABSTRACT:
The present invention relates generally to compositions and methods using mammalian, dsDNA (Double Stranded Deoxyribonucleic Acid) vaccination for the induction and maintenance of regulator suppressor T cells resulting in suppression of non infectious, and post infectious, inflammatory, allergic, auto-immune, vasculitic, certain degenerative vascular, and graft versus host diseases, with or without the use of IL-10, and with or without the use or TGFβ, with or without the use of anti-IL 6 receptor antibody, anti TNF antibody and or Plasmapheresis, IVIG, Corticosteroids, Methotrexate, Bromocriptine, and or vitamin D analogues.
REFERENCES:
patent: 4452794 (1984-06-01), Kort et al.
patent: 5955443 (1999-09-01), Bennett et al.
patent: 6008344 (1999-12-01), Bennett et al.
patent: 6447765 (2002-09-01), Horwitz
patent: 2001/0004456 (2001-06-01), Tobinick
patent: 2002/0064826 (2002-05-01), Ruben et al.
patent: 2005/0239733 (2005-10-01), Jurk et al.
Shuman et al. Journal of Biological Chemistry 1993, vol. 268, pp. 18943-18950.
Kalota et al. Handbook of Experimental Pharmacology 2006, vol. 173, pp. 173-196.
Sano et al. PNAS 1982, vol. 79, pp. 3584-3588.
Chen et al. Gene Therapy 2001, vol. 8, pp. 1024-1032.
Stacey et al. Journal of Immunology 2003, vol. 170, pp. 3614-3620.
Gursel et al. Journal of Immunology 2003, vol. 171, pp. 1393-1400.
Blass, “Immunologic Treatment of Alzheimer's Disease”, Clinical Implications of Basic Research, vol. 341, No. 22, 1694-1695, Nov. 25, 1999, New England Journal Medicine.
Mitch Leslie, “Mindful of Metal”; http://sageke.sciencemag.org/cgi/content/full/sageke;, Mar. 26, 2003.
Saunders et al., “The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:85-94.
Checler et al., “Role of the proteasome in Alzheimer's disease”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:133-138 Abstract.
Emmerling et al., “The role of complement in Alzheimer's disease pathology”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:158-171.
Michael A. Boss, “Diagnostic approaches to Alzheimer's disease”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:188-200.
Venters, et al., “A new concept in neurodegneneration: TNFα is a silencer of survival signals”, Trends in Neurosciences, 2000, vol. 23, No. 4, pp. 175-180.
Rudd, et al., “Cbl sets the threshold for autoimmunity”, Current Biology,2000, 10:R344-R347.
Daniel L. Mueller, “A proliferation of costimulatory molecules”, Current Biology 2000, 10:R227-R230.
Hakon Heimer, “Outer causes of inner conflicts: Environment and Autoimmunity”, Environmental Health Perspectives, vol. 107, No. 10, Oct. 1999.
Colin Watts, “Capture and Processing of Exogenous Antigens for Presentation on MHC Molecules”, Annu. Rev. Immunol. 1997, vol. 15, pp. 821-850.
Taneja, et al., “Lessons from animal models for human autoimmune diseases”, Nature Immunology, vol. 2, pp. 781-784, 2001.
Gregg J. Silverman, “B cell superantigens: possible roles in immunodeficiency and autoimmunity”, Immunology, vol. 10, 1998, pp. 43-55.
Schmitt, et al., “Clinical Applications of Antineutrophil Cytoplasmic Antibody Testing”, Curr Opin Rheumatol, vol. 16, No. 1, pp. 9-17, 2004.
Rogers, et al., “A Perspective on Inflammation in Alzheimer's Disease”, Annals of the New York Academy of Sciences, vol. 924, pp. 132-135, (2000).
Janus, et al., “Transgenic mouse models of Alzheimer's disease”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:63-75.
Golde, et al., “Biochemical detection of Aβisoforms: implications for pathogenesis, diagnosisi, and treatment of Alzheimer's disease”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:172-187.
Akihiko Iwai, “Properties of NACP/α-synuclein and its role in Alzheimer's disease”, Biochimica et Biophysica Acta (BBA)/Molecular Basis of Disease 2000, 1502:95-109—Abstract.
Haley, et al., “The Relationship of the Toxic Effects of Mecury to Exacerabation of the Medical Condition Classified as Alzheimer's Disease”, http://www.alzforum.org/res/adh/hyp/mercury.asp, Aug. 13, 2001.
McGeer, et al., “Inflammation and the Degenerative Diseases of Aging” Annals NY Acad Sci, vol. 1035, pp. 104-116, (2004).
Du, et al., “Association of an interleukin 1α polymorphism with Alzheimer's disease”, Neurology, vol. 55, pp. 480-484, (2000)—Abstract.
Smith, et al., “Oxidative Stress in Alzheimer's disease”, Biochemica et Biophysica Acta/Molecular Basis of Disease, vol. 1502, pp. 39-144, (2000).
SantaCruz, et al., “Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function”, Science, vol. 309, pp. 476-481, (2005).
Clark et al., “CD40 and Its Ligand”, Adv. Immunol., vol. 63, pp. 43-78, (1996).
Hathcock et al., “Role of the CD28-B7 Costimulatory Pathways in T Cell-Dependent B Cell Responses”, Adv. Immunol.,.vol. 62, pp. 131-166, (1996).
Tero Tapiola, “Biological Markers for Alzheimer's Disease”, Doctoral Dissertation, ISBN 951-781-749-5, (2001).
Griem, et al., “Allergic and autoimmune reactions to xenobiotics: how do they arise?”, Immunol. Today 19(3), pp. 133-141 (1998).
Pamela L. Schwartzberg, “Tampering with Immune System”, Science 293 (5528): 228 (2001).
Syamal K. Datta, “Positive selection for autoimmunity”, Nature Med., vol. 6, No. 3, pp. 259-261, Mar. 2000.
Davidson et al., “Autoimmune Diseases”, Adv. Immunol. vol. 345, pp. 340-350, (2001), NEJM.
Blanco, et al., “Cytotoxic T Lymphocytes and Autoimmunity”, CurrOpin Rheumatol., vol. 17, No. 6, pp. 731-734, (2005).
Rolf M. Zinkernagel, “Antiinfection Immunity and Autoimmunity”, Annals of the New York Academy of Sciences, vol. 958, pp. 3-6, (2002).
John Hardy, “The Alzheimer family of diseases: Many etiologies, one pathogeneis?”, Proc. Natl. Acad. Sci. USA: vol. 94, No. 6, pp. 2095-2097, (1997).
Jean Marx, “Preventing Alzheimer's: A Lifelong Commitment?”, Science, vol. 309, Issue 5736, pp. 864-866, Aug. 5, 2005.
Koch, et al., “T-CIA: Investigating T Cells in Aging”, Sci. Aging Knowl. Environ. vol. 2005, Issue 27, pp. pe21, Jul. 6, 2005.
Carina Treiber, “Metals on the Brain”, Sci. Aging Knowledge, vol. 2005, Issue 36, pp. pe27, Sep. 7, 2005.
Tom Clarke, “Painkillers show Alzheimer's promise”, http://www.nature.com
su/011108/011108-10.html.
Cooper et al., “Role of genetic Factos in autoimmune disease: implications for environmental research”, Environ. Health Perspect, vol. 107, Suppl5, 1999, pp. 693-700—Abstract.
Lawless Oliver
Pillsbury Winthrop Shaw & Pittman LLP
Vivlemore Tracy
LandOfFree
Vaccine composition comprising methylated DNA and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition comprising methylated DNA and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition comprising methylated DNA and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639015